Literature DB >> 17013488

Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.

Mansour S Al-Moundhri1, Khaled Al-Thahli, Said Al-Kindy, Jamal Salam, Lakshmi Rao.   

Abstract

A 45-year-old man suffering from intermittent rectal bleeding was diagnosed with ulcerative colitis involving the descending colon and rectum. After 2 years on ulcerative colitis treatment, he presented with metastatic gastrointestinal tumor, liver and peritoneal spread, and a pelvic mass. Interestingly, he was found to have significant hypercalcemia. He was treated with Imatinib with significant symptomatic and clinical response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17013488

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  4 in total

1.  Refractory hypercalcaemia secondary to localised gastrointestinal stromal tumour.

Authors:  T Hart; D Sinitsky; A Shamsiddinova; A Rohatgi
Journal:  Ann R Coll Surg Engl       Date:  2018-04-16       Impact factor: 1.891

2.  Gastrointestinal Stromal Tumor Induced Hypercalcemia.

Authors:  Aram Barbaryan; Stefania Bailuc; Padma Poddutoori; Aida Richardson; Aibek E Mirrakhimov
Journal:  Case Rep Oncol Med       Date:  2017-04-06

Review 3.  Calcitriol-Mediated Hypercalcemia, Somatostatin Receptors Expression and 25-Hydroxyvitamin D3-1α- Hydroxylase in GIST Tumors.

Authors:  Yiraldine Herrera-Martínez; María José Contreras González; Sergio Pedraza-Arévalo; Maria Del Carmen Guerrero Martínez; Ángela Rodrigo Martínez; Alberto González Menchen; Maria Angeles Blanco Molina; Maria Angeles Gálvez-Moreno; Alberto L Moreno-Vega; Raúl M Luque; Aura D Herrera-Martínez
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-26       Impact factor: 5.555

Review 4.  Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature.

Authors:  Katrine Hygum; Christian Nielsen Wulff; Torben Harsløf; Anders Kindberg Boysen; Philip Blach Rossen; Bente Lomholt Langdahl; Akmal Ahmed Safwat
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.